Services

Case Report Form Design
Coding and reporting Adverse Effects
Electronic data submission and electronic reports
Phase 1 & 2 / bioequivalence clinical trials
Phenotyping/Genotyping studies
Quality Assurance
Recruiting of healthy subjects and special populations

Experience

Age/Gender
Bioavailabilty
Bioequivalence
Dermal PK
Drug delivery in vivo testing
First Time in Human
Food Effects
Genotyping studies
Medical Services
Pharmacodynamics
Pharmacokinetics
Safety and Tolerability
Single and Multiple dose escalation with on-line PK analysis
Skin irritation and Sensitization studies
Vaccines
Vasoconstrictor
Schedule II and III Compounds
QT/QTc Intervals

Special Populations Database

Allergic rhinitis
Asthmatic (adult/pediatric)
Cardiovascular Disease
Diabetics, type I and II
Elderly subjects
Fast/Slow metabolizers in CYP2D6, CYP2C9, and CYP2C19
Healthy male/female
Healthy pediatric subjects
Healthy geriatric
Healthy premenopausal women with regular menstrual cycles w/ and without oral contraceptives
Hepatitis C
HIV Positive
Osteo/rheumatoid arthritis
Obese subjects
Hypertensive
Postmenopausal women
Surgically sterile postmenopausal women
Patients with peptic ulcer(PUD), and gastroesophageal reflux (GERD)

Therapeutic Areas

Women's Health
Pulmonary
Pain Management
Ophthalmology
Infectious diseases
Immunology
Hypertension
Hyperlipidemia
Genitourinary
Gastrointestinal
Endocrinology
Dermatology
Central Nervous System
Cardiovascular
Oncology